Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 200.89
-9.43 (-4.48%)
At close: Feb 6, 2026
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 31.5 billion as of February 6, 2026. Its market cap has decreased by -18.60% in one year.
Market Cap
31.50B
Enterprise Value
50.77B
Revenue
27.97B
Ranking
n/a
PE Ratio
26.49
Stock Price
200.89
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 31.50B, a decrease of -44.57%. That is a compound annual growth rate of -6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 32.97B | -15.05% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 595.24B |
| Anthem Biosciences | 356.62B |
| OneSource Specialty Pharma | 133.20B |
| Concord Biotech | 122.21B |
| Blue Jet Healthcare | 70.55B |
| Supriya Lifescience | 53.84B |
| Zota Health Care | 43.68B |
| Panacea Biotec | 22.79B |